JPMorgan Chase & Co’s Agilon Health AGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.56M | Sell |
680,245
-954,229
| -58% | -$2.19M | ﹤0.01% | 3485 |
|
|
2025
Q1 | $7.08M | Buy |
1,634,474
+1,385,128
| +556% | +$6M | ﹤0.01% | 2432 |
|
|
2024
Q4 | $474K | Sell |
249,346
-1,166,073
| -82% | -$2.22M | ﹤0.01% | 4180 |
|
|
2024
Q3 | $5.56M | Buy |
1,415,419
+937,092
| +196% | +$3.68M | ﹤0.01% | 2571 |
|
|
2024
Q2 | $3.13M | Buy |
478,327
+1,638
| +0.3% | +$10.7K | ﹤0.01% | 2811 |
|
|
2024
Q1 | $2.91M | Buy |
476,689
+208,589
| +78% | +$1.27M | ﹤0.01% | 2902 |
|
|
2023
Q4 | $3.36M | Buy |
268,100
+81,634
| +44% | +$1.02M | ﹤0.01% | 2813 |
|
|
2023
Q3 | $3.31M | Buy |
186,466
+83,590
| +81% | +$1.48M | ﹤0.01% | 2678 |
|
|
2023
Q2 | $1.78M | Sell |
102,876
-3,227
| -3% | -$56K | ﹤0.01% | 3100 |
|
|
2023
Q1 | $2.52M | Buy |
106,103
+5,338
| +5% | +$127K | ﹤0.01% | 2903 |
|
|
2022
Q4 | $1.63M | Buy |
100,765
+6,044
| +6% | +$97.5K | ﹤0.01% | 3089 |
|
|
2022
Q3 | $2.22M | Buy |
94,721
+12,747
| +16% | +$298K | ﹤0.01% | 2846 |
|
|
2022
Q2 | $1.79M | Sell |
81,974
-176,177
| -68% | -$3.84M | ﹤0.01% | 3087 |
|
|
2022
Q1 | $6.55M | Buy |
258,151
+249,405
| +2,852% | +$6.32M | ﹤0.01% | 2367 |
|
|
2021
Q4 | $237K | Buy |
8,746
+799
| +10% | +$21.7K | ﹤0.01% | 4445 |
|
|
2021
Q3 | $208K | Buy |
7,947
+1,663
| +26% | +$43.5K | ﹤0.01% | 4393 |
|
|
2021
Q2 | $255K | Buy |
+6,284
| New | +$255K | ﹤0.01% | 4365 |
|